Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02038647 |
|---|---|
| Brief Title: | Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC) |
| First Submitted : | December 4, 2013 |
| First Submitted that Met QC Criteria : | January 14, 2014 |
| First Posted : | January 16, 2014 (Estimate) |
| Results First Submitted : | February 21, 2018 |
| Results First Submitted that Met QC Criteria : | December 3, 2018 |
| Results First Posted : | December 27, 2018 |
| Last Update Submitted that Met QC Criteria : | December 3, 2018 |
| Last Update Posted : | December 27, 2018 |